PrEP Readiness Interventions for Supporting Motivation in Stimulant-Using Sexual Minority Men
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- HIV Infections
- Sponsor
- Florida International University
- Enrollment
- 70
- Locations
- 1
- Primary Endpoint
- Proportion of Participants Filling a Prescription for PrEP
- Status
- Completed
- Last Updated
- 10 months ago
Overview
Brief Summary
The overarching goal of this formative research is to examine whether, and in what combination, contingency management (CM) and motivational interviewing (MI) can facilitate entry of stimulant-using men who have sex with men (MSM) into the pre-exposure prophylaxis (PrEP) care continuum.
Detailed Description
In Stage 1, participants will be randomized to receive either: 1) three months of CM; or 2) two sessions of MI. All participants will be assessed at three months post-randomization for non-response. In Stage 2, a second randomization where non-responders (i.e., those who have not filled a PrEP prescription) are assigned to: 1) Switch to sequentially receive the other intervention (i.e., CM+MI or MI+CM); or 2) Continue with assessments only (i.e., CM-Only or MI-Only). All participants will complete a final assessment at 6 months.
Investigators
Adam Carrico, PhD
Professor and Chair
Florida International University
Eligibility Criteria
Inclusion Criteria
- •At least 18 years of age
- •Sexually active cisgender sexual minority man
- •Reports using stimulants in the past three months
- •HIV-negative serostatus
- •Meets Centers for Disease Control and Prevention (CDC) criteria for PrEP eligibility
Exclusion Criteria
- •Currently prescribed PrEP
- •Unable to provide informed consent
- •Severe psychiatric symptoms (e.g., mania, psychosis) that impair capacity to participate
Outcomes
Primary Outcomes
Proportion of Participants Filling a Prescription for PrEP
Time Frame: 6 Months
The proportion of participants who provide evidence that they have filled a PrEP prescription
Secondary Outcomes
- Proportion of Participants Who Self-report PrEP Clinical Evaluation by a Medical Provider(6 Months)
- Clinical Cut Points for Self-reported Methamphetamine Use Severity(6 months)
- Proportion of Participants Who Reported Receptive Condomless Anal Sex (Receptive CAS)(6 months)
- Proportion of Participants Who Reported Insertive Condomless Anal Sex (Insertive CAS)(6 months)